Philip James Wealth Mangement LLC Sells 565,281 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Philip James Wealth Mangement LLC trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 97.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,782 shares of the pharmacy operator's stock after selling 565,281 shares during the quarter. Philip James Wealth Mangement LLC's holdings in Walgreens Boots Alliance were worth $187,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of WBA. Riverview Trust Co grew its holdings in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after acquiring an additional 1,590 shares during the last quarter. Colonial Trust Co SC increased its holdings in shares of Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,297 shares in the last quarter. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $27,000. Curat Global LLC acquired a new position in Walgreens Boots Alliance during the 1st quarter worth $27,000. Finally, Private Trust Co. NA lifted its holdings in Walgreens Boots Alliance by 35.5% during the 4th quarter. Private Trust Co. NA now owns 4,585 shares of the pharmacy operator's stock worth $43,000 after buying an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on WBA shares. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a "hold" rating for the company. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Finally, Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $10.59.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of Walgreens Boots Alliance stock in a transaction dated Sunday, April 27th. The stock was bought at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman directly owned 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 17.50% of the stock is owned by company insiders.

Walgreens Boots Alliance Stock Up 0.1%

Shares of Walgreens Boots Alliance stock traded up $0.01 during trading on Tuesday, reaching $11.49. The stock had a trading volume of 7,308,860 shares, compared to its average volume of 19,925,320. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $9.95 billion, a price-to-earnings ratio of -1.58, a P/E/G ratio of 1.36 and a beta of 0.78. The stock has a fifty day moving average price of $11.22 and a two-hundred day moving average price of $10.85. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. During the same period last year, the company earned $0.63 earnings per share. The firm's revenue was up 7.2% compared to the same quarter last year. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.